Predicting the combined occurrence of poor clinical and radiographic outcomes following cervical deformity corrective surgery.

AUC = area under the curve CBVA = chin-brow vertical angle CD = cervical deformity CL = C2–7 lordosis MCID = minimum clinically important difference NDI = Neck Disability Index PI-LL = mismatch between pelvic incidence and lumbar lordosis PT = pelvic tilt SVA = sagittal vertical axis TS-CL = mismatch between T1 slope and CL cSVA = C2–7 SVA cervical deformity complications mJOA = modified Japanese Orthopaedic Association poor outcome predictive analytics sagittal malalignment

Journal

Journal of neurosurgery. Spine
ISSN: 1547-5646
Titre abrégé: J Neurosurg Spine
Pays: United States
ID NLM: 101223545

Informations de publication

Date de publication:
01 Nov 2019
Historique:
received: 25 05 2018
accepted: 09 07 2019
pubmed: 2 11 2019
medline: 1 7 2020
entrez: 2 11 2019
Statut: ppublish

Résumé

Cervical deformity (CD) correction is clinically challenging. There is a high risk of developing complications with these highly complex procedures. The aim of this study was to use baseline demographic, clinical, and surgical factors to predict a poor outcome following CD surgery. The authors performed a retrospective review of a multicenter prospective CD database. CD was defined as at least one of the following: cervical kyphosis (C2-7 Cobb angle > 10°), cervical scoliosis (coronal Cobb angle > 10°), C2-7 sagittal vertical axis (cSVA) > 4 cm, or chin-brow vertical angle (CBVA) > 25°. Patients were categorized based on having an overall poor outcome or not. Health-related quality of life measures consisted of Neck Disability Index (NDI), EQ-5D, and modified Japanese Orthopaedic Association (mJOA) scale scores. A poor outcome was defined as having all 3 of the following categories met: 1) radiographic poor outcome: deterioration or severe radiographic malalignment 1 year postoperatively for cSVA or T1 slope-cervical lordosis mismatch (TS-CL); 2) clinical poor outcome: failing to meet the minimum clinically important difference (MCID) for NDI or having a severe mJOA Ames modifier; and 3) complications/reoperation poor outcome: major complication, death, or reoperation for a complication other than infection. Univariate logistic regression followed by multivariate regression models was performed, and internal validation was performed by calculating the area under the curve (AUC). In total, 89 patients with CD were included (mean age 61.9 years, female sex 65.2%, BMI 29.2 kg/m2). By 1 year postoperatively, 18 (20.2%) patients were characterized as having an overall poor outcome. For radiographic poor outcomes, patients' conditions either deteriorated or remained severe for TS-CL (73% of patients), cSVA (8%), horizontal gaze (34%), and global SVA (28%). For clinical poor outcomes, 80% and 60% of patients did not reach MCID for EQ-5D and NDI, respectively, and 24% of patients had severe symptoms (mJOA score 0-11). For the complications/reoperation poor outcome, 28 patients experienced a major complication, 11 underwent a reoperation, and 1 had a complication-related death. Of patients with a poor clinical outcome, 75% had a poor radiographic outcome; 35% of poor radiographic and 37% of poor clinical outcome patients had a major complication. A poor outcome was predicted by the following combination of factors: osteoporosis, baseline neurological status, use of a transition rod, number of posterior decompressions, baseline pelvic tilt, T2-12 kyphosis, TS-CL, C2-T3 SVA, C2-T1 pelvic angle (C2 slope), global SVA, and number of levels in maximum thoracic kyphosis. The final model predicting a poor outcome (AUC 86%) included the following: osteoporosis (OR 5.9, 95% CI 0.9-39), worse baseline neurological status (OR 11.4, 95% CI 1.8-70.8), baseline pelvic tilt > 20° (OR 0.92, 95% CI 0.85-0.98), > 9 levels in maximum thoracic kyphosis (OR 2.01, 95% CI 1.1-4.1), preoperative C2-T3 SVA > 5.4 cm (OR 1.01, 95% CI 0.9-1.1), and global SVA > 4 cm (OR 3.2, 95% CI 0.09-10.3). Of all CD patients in this study, 20.2% had a poor overall outcome, defined by deterioration in radiographic and clinical outcomes, and a major complication. Additionally, 75% of patients with a poor clinical outcome also had a poor radiographic outcome. A poor overall outcome was most strongly predicted by severe baseline neurological deficit, global SVA > 4 cm, and including more of the thoracic maximal kyphosis in the construct.

Identifiants

pubmed: 31675700
doi: 10.3171/2019.7.SPINE18651
pii: 2019.7.SPINE18651
doi:
pii:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

182-190

Auteurs

Samantha R Horn (SR)

1Department of Orthopaedics, NYU Langone Medical Center-Orthopaedic Hospital, New York, New York.

Peter G Passias (PG)

1Department of Orthopaedics, NYU Langone Medical Center-Orthopaedic Hospital, New York, New York.

Cheongeun Oh (C)

1Department of Orthopaedics, NYU Langone Medical Center-Orthopaedic Hospital, New York, New York.

Virginie Lafage (V)

2Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York.

Renaud Lafage (R)

2Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York.

Justin S Smith (JS)

3Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia.

Breton Line (B)

4Denver International Spine Center, Presbyterian/St. Luke's Medical Center and Rocky Mountain Hospital for Children, Denver, Colorado.

Neel Anand (N)

5Department of Orthopaedic Surgery, Cedars-Sinai Medical Center, Los Angeles, California.

Frank A Segreto (FA)

1Department of Orthopaedics, NYU Langone Medical Center-Orthopaedic Hospital, New York, New York.

Cole A Bortz (CA)

1Department of Orthopaedics, NYU Langone Medical Center-Orthopaedic Hospital, New York, New York.

Justin K Scheer (JK)

6Department of Neurosurgery, University of Illinois at Chicago, Illinois.

Robert K Eastlack (RK)

7Department of Orthopaedic Surgery, Scripps Health, La Jolla, California.

Vedat Deviren (V)

8Department of Orthopaedic Surgery, University of California, San Francisco, California.

Praveen V Mummaneni (PV)

8Department of Orthopaedic Surgery, University of California, San Francisco, California.

Alan H Daniels (AH)

9Department of Orthopaedic Surgery, Brown University Medical Center, Providence, Rhode Island.

Paul Park (P)

10Department of Neurosurgery, University of Michigan, Ann Arbor, Michigan.

Pierce D Nunley (PD)

11Department of Orthopedic Surgery, Spine Institute of Louisiana, Shreveport, Louisiana.

Han Jo Kim (HJ)

2Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York.

Eric O Klineberg (EO)

12Department of Orthopedic Surgery, University of California Davis, Sacramento, California.

Douglas C Burton (DC)

13Department of Orthopaedic Surgery, University of Kansas Medical Center, Kansas City, Kansas.

Robert A Hart (RA)

14Department of Orthopaedic Surgery, Swedish Neuroscience Institute, Seattle, Washington; and.

Frank J Schwab (FJ)

2Department of Orthopaedic Surgery, Hospital for Special Surgery, New York, New York.

Shay Bess (S)

4Denver International Spine Center, Presbyterian/St. Luke's Medical Center and Rocky Mountain Hospital for Children, Denver, Colorado.

Christopher I Shaffrey (CI)

3Department of Neurosurgery, University of Virginia Health System, Charlottesville, Virginia.

Christopher P Ames (CP)

15Department of Neurological Surgery, University of California, San Francisco, California.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH